362 results on '"Gandia, Peggy"'
Search Results
2. A biological pharmacology network to secure the risk of drug–drug interaction with nirmatrelvir/ritonavir
3. Exploration of the relationship between cumulative exposure to tobramycin and ototoxicity in patients with cystic fibrosis
4. Optimization of ICP-MS internal standardization for 26 elements by factorial design experiment
5. Maternal drugs and breastfeeding: Risk assessment from pharmacokinetics to safety evidence - A contribution from the ConcePTION project
6. “De-Shrinking” EBEs: The Solution for Bayesian Therapeutic Drug Monitoring
7. Evaluation of 4 quantification methods for monitoring 16 antibiotics and 1 beta-lactamase inhibitor in human serum by high-performance liquid chromatography with tandem mass spectrometry detection
8. A comprehensive review on non-clinical methods to study transfer of medication into breast milk – A contribution from the ConcePTION project
9. Transfer of cetirizine/levocetirizine into human breast milk and estimation of drug exposure to infants through breastfeeding : A human lactation study from the ConcePTION project
10. Safety of Pyrazinamide for the Treatment of Tuberculosis in Older Patients Over 75 Years of Age: A Retrospective Monocentric Cohort Study
11. Transfer of cetirizine/levocetirizine into human breast milk and estimation of drug exposure to infants through breastfeeding: A human lactation study from the ConcePTION project
12. Dosage des médicaments antihypertenseurs en France en 2019 et observance
13. Pourquoi, comment et où dose-t-on les antihypertenseurs en 2019 ?
14. Why Were More Than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One?
15. Authors’ Reply to Yu et al.: “Levothyrox® New and Old Formulations: Are They Switchable for Millions of Patients?”
16. Authors’ Reply to Nicolas: “Why Were More than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One?”
17. Levothyrox® New and Old Formulations: Are they Switchable for Millions of Patients?
18. Isavuconazole Kinetic Exploration for Clinical Practice
19. Infant exposure to Fluvoxamine through placenta and human milk: a case series - A contribution from the ConcePTION project
20. Severe Metabolic Failures After Recreational Ingestion of γ-Butyrolactone
21. Comparing ultrafiltration and equilibrium dialysis to measure unbound plasma dolutegravir concentrations based on a design of experiment approach
22. Influence of extracorporeal membrane oxygenation on the pharmacokinetics of ceftolozane/tazobactam: an ex vivo and in vivo study
23. Authors’ Reply to Castello-Bridoux et al.: “Comment on Levothyrox® New and Old Formulations: Are they Switchable for Millions of Patients?”
24. Authors’ Reply to Nicolas: “Levothyrox® New and Old Formulations: Are they Switchable for Millions of Patients?”
25. Biased computation of probability of target attainment for antimicrobial drugs
26. Hypoalbuminemia and Pharmacokinetics: When the Misunderstanding of a Fundamental Concept Leads to Repeated Errors over Decades
27. Infant exposure to Fluvoxamine through placenta and human milk:a case series - A contribution from the ConcePTION project
28. Safety of medicines during breastfeeding–from case report to modeling:a contribution from the ConcePTION project
29. Maternal drugs and breastfeeding:Risk assessment from pharmacokinetics to safety evidence - A contribution from the ConcePTION project
30. Quinine unbound concentration is the best marker for therapeutic drug monitoring
31. HIV-1 escape in the central nervous system on elvitegravir-based antiretroviral therapy
32. Optimization of the treatment with beta-lactam antibiotics in critically ill patients—guidelines from the French Society of Pharmacology and Therapeutics (Société Française de Pharmacologie et Thérapeutique—SFPT) and the French Society of Anaesthesia and Intensive Care Medicine (Société Française d’Anesthésie et Réanimation—SFAR)
33. Évaluation des risques liés aux médicaments pendant l’allaitement
34. Optimization of Icp-Ms Internal Standardization for 26 Elements by Factorial Design Experiment
35. Method validation and clinical application for the quantification of lopinavir, efavirenz, and ritonavir in breast milk using liquid chromatography tandem mass spectrometry
36. Safety of medicines during breastfeeding – from case report to modeling: a contribution from the ConcePTION project
37. Population Pharmacokinetic Approach Applied to Positron Emission Tomography: Computed Tomography for Tumor Tissue Identification in Patients with Glioma
38. Population Pharmacokinetics of Tracers: A New Tool for Medical Imaging?
39. Tuberculose : intérêt du dosage de l’isoniazide dans la prévention des effets hépatotoxiques
40. ANTIHYPERTENSEURS - MODELISATION PK/PD
41. TOXICITE des AMINOSIDES - MODELISATION PK/PD
42. ANTIBIOTIQUES et EFFICACITE MICROBIOLOGIQUE
43. ANESTHESIE GENERALE - MODELISATION PK/PD
44. CONCEPTS FONDAMENTAUX en MODELISATION PHARMACOCINETIQUE-PHARMACODYNAMIQUE
45. Authors’ Reply to Lechat et al.: “Levothyrox® New and Old Formulations: Are they Switchable for Millions of Patients?”
46. Authors’ Reply to Coste et al.: “Levothyrox® New and Old Formulations: Are they Switchable for Millions of Patients?”
47. Author’s Reply to Trechot: “Comment on Levothyrox® New and Old Formulations: Are they Switchable for Millions of Patients?”
48. Determination of unbound fraction of imatinib and N-desmethyl imatinib, validation of an UPLC–MS/MS assay and ultrafiltration method
49. Evaluation of 4 Quantification Methods for the Monitoring of 16 Antibiotics and 1 Beta-Lactamase Inhibitor in Human Serum by High-Performance Liquid Chromatography with Tandem Mass Spectrometry Detection
50. Quantification of topotecan by liquid chromatography–mass spectrometry (LC–MS). Application to intestinal transport using rat everted gut sacs
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.